First ever treatment for face-blindness discovered
An optician has come up with a pioneering new treatment to cure people of the face-blindness condition.
Relating to the inability to recognisefacial expressions, face-blindness is otherwise known by its technical term, prosopagnosiaand affects one in 40 people.
The new treatment for face-blindness involves altering the visual perception pathways by using coloursto enhance the subject being looked at; faces in this case.
Once the most effective colourhas been identified, patients are prescribed tailor made glasses with lenses in that shade.
READ MORE FROM THE WDM CONTENT NETWORK:
To read the latest edition of Healthcare Global, click here
- Welsh scheme to cut hospital admissions could go global
- Global health prize won by jailed Iran doctors
- Miracle genetic code finding could prevent fatal diseases
Face-blindness is often a result of a brain trauma and is particularly common in those who are on the autistic spectrum.
Ian Jordan, an optometrist from Scotland, discovered the treatment by accident while treating a patient for a different sensory condition.
Speaking about the treatment in an interview he said: “This is a real breakthrough and will be life-changing for those with prosopagnosia.”
“Until now, there hasn't been any way to treat it - just techniques and strategies to deal with the consequences.”
He added: “Some people are able to piece together a person's identity by recognisingthe way they walk or the sound of their voice, but the prospect of meeting and having to identify new people, either socially, at work or at school, can be very distressing.”
Patients who have received the treatment cannot speak highly enough of it. Isabelle Thoraldsaid: “When I put the glasses on, everything looks a hundred times better. I can see a whole face at once.”
Meanwhile, Alan Mandelsonsaid: “It gave me more confidence to go out and actually try to socialise.”
Ian Jordan will now be presenting his findings in London at the Treating Autism 7th Biomedical Conference and Exhibition.
- Synairgen’s inhaled COVID-19 treatment trial successTeleHealth & COVID-19
- Interpace introduces ‘invaluable’ new lung cancer testTechnology & AI
- The rise of medical tourism is impacting stem cell treatmentsHospitals
- The number of private health facilities in Dubai is increasingDigital Healthcare
Featured Articles
NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system
Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment
A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency